Berry, N.
Peters, S.
Haddock, G.
Scott, A.
Harris, K.
Cook, L.
Awenat, Y.
Gooding, P. A.
Funding for this research was provided by:
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (13/161/25)
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (13/161/25)
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (13/161/25)
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (13/161/25)
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (13/161/25)
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (13/161/25)
This project is funded by the Efficacy and Mechanism Evaluation (EME) Programme (13/161/25)
This work is supported by NIHR Manchester Biomedical Research Centre (NIHR203308)
Article History
Received: 2 April 2024
Accepted: 10 September 2024
First Online: 3 December 2024
Declarations
:
: The current study was approved by a National Health Service (NHS) Research Ethics Committee (reference: 17/NW/0089). Relevant ethical and legal guidelines concerning confidentiality and the storage of personal data were followed (e.g., General Data Protection Regulation). Signed informed consent forms by participants and countersigned by CARMS team staff were stored on NHS and/or University secure servers separate to the research data.
: Participants provided signed informed consent for quotes to be used for publications.
: The views expressed in this publication are those of the author(s) and not necessarily those of the MRC, NIHR, or the Department of Health and Social Care. The CARMS trial is hosted by Greater Manchester Mental Health NHS Foundation Trust, UK. The Sponsor is the University of Manchester, UK.
: This work is supported by the NIHR Manchester Biomedical Research Centre (NIHR203308). No authors have any other conflicts of interest to declare.